Smart Pharma – Technology brings Unprecedented Opportunities
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Increased R&D costs, regulatory hurdles, and the emergence of new diseases are enforcing pharmaceutical companies to rethink their aging business models. The highly regulated pharma is gradually adopting emerging technologies to improve every aspect of the value chain, from drug discovery to patient care. Moreover, the urgency around the COVID-19 pandemic has accelerated the need to embrace digital technologies.
Pharma companies, researchers, innovators, and authorities now aim to unlock the full potential of emerging technologies like AI, big data, IoT, robotics, and 3D printing. The report focuses on how the pharmaceutical sector is leveraging emerging technologies to drive innovation and marching towards massive transformation.
Scope
Theme Exposure Map: presents the top themes impacting the sector over the last three years compared to other sectors.
Patent Filings Chart: displays the top ten themes in the sector with the highest number of patent filings over the last three years.
Innovation Map: key real-world innovation use cases of emerging technologies implemented by enterprises and startups in the sector.
Innovation Insights: innovation examples by each value chain segment of the sector to present key trends.
Vendor Map: represents a sample list of vendors in each use case highlighted in the report.
Key Highlights
Innovations: presents real-world innovation use cases and examples related to the implementation of emerging technologies by companies as well as startups in the pharmaceutical sector. It casts light on how tech-enabled innovations are transforming every segment of the sector value chain.
Reasons to Buy
No surprise that technology has been a driving force in business transformation for years, but the term ‘emerging technologies’ has all of the sudden became the key catalyst to drive the next wave of innovation across sectors.
The sense of urgency weighs different across different sectors, where the direct customer-facing sectors are at the forefront compared to other capital-intensive sectors. Companies in one sector can take cues from successful innovations in other sectors to either draw analogies with existing products, services and processes or transfer strategic approaches for a revolutionary transformation.
Against this backdrop, enterprises need to understand which emerging technologies are impacting their sector and how various companies are implementing them to meet various challenges.
The innovation landscape report in pharma, published by GlobalData as part of an ongoing series, covers some of the key trends, use cases, and real-world examples related to the implementation of emerging technologies across the pharma sector value chain.
Gero
Cold Spring
Nvidia
TwoXAR
Massachusetts Institute of Technology
Exscientia
AstraZeneca
Elucid
Schreiner
TrialJectory
Deep 6
Agios
Evaluate
Cambridge Cognition
G42 Healthcare
FabRx
Aprecia
Vitronic
Optel
OnRobot
Vetter
Pii
BellatRx
Merck
Matternet
Wake Forest Baptist Health
OneEvent
SkyCell
Smartrac
IBM
Microsoft
Novartis
Abbott India
GoodRx
Medibox
BeMyEye
DotActive
Viscira
PatientKeeper
VeChain
BlueDot
Biobot
MicroSure
Washigton University School of Medicine
Doctor on Demand
Eko
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.